Regulatory News In Brief

Ortho Molecular supplement claims draw warning letter; FDA flags Global Source Management violations; Zi Xiu Tang bee pollen capsules recall follows FDA buzz; Wal-Born users eligible for refunds, FTC says; GAO endorses FDA comparability approach to food import safety.